Vizientinc.com does not support this browser (Internet Explorer)
This will impact your experience of the Vizient website and may prevent you from accessing certain features and important security updates.
To improve your browsing experience we recommend you upgrade your browser to Safari, Chrome, Microsoft Edge or Firefox
With direct letters, regulatory comments and other activities, Vizient strives to form constructive relationships with lawmakers, regulatory agencies and administration officials, to provide a unified voice on issues that have a direct impact on our members.
Advocacy 2023
March 21 - Vizient endorsed coalition letter calling for $738 million in FY 2024 funding for Children’s Hospital Graduate Medical Education (CHGME)
Vizient, Inc.
March 20 - Vizient comments to the to the Department of Labor (DoL) Employment and Training Administration (ETA) on the request for information (RFI) on sector strategies to meet critical workforce needs across industries, including healthcare.Vizient, Inc.
March 20 - Vizient comments to the Senate Health, Education, Labor & Pensions (HELP) Committee on the request for information (RFI) regarding healthcare workforce challengesVizient, Inc.
March 13 - Vizient shares feedback with House members on the reauthorization of the Pandemics and All-Hazards Preparedness Act (PAHPA)Vizient, Inc.
March 13 - Vizient comments to CMS on prior authorization proposed ruleVizient, Inc.
March 6 - Vizient urges Congress to address the Medicaid disproportionate share hospital (DSH) cuts scheduled to begin in fiscal year (FY) 2024Vizient, Inc.
February 13 - Vizient comments to CMS on the Contract Year 2024 Medicare Advantage and Part D Proposed RuleVizient, Inc.
February 2 - Vizient submits comments to FDA regarding Drug Supply Chain Security Act (DSCSA) Implementation and Readiness Efforts for 2023Vizient, Inc.
January 31 - Vizient submits comments to HHS regard Confidentiality of Substance Use Disorder Patient RecordsVizient, Inc.
January 30 - Vizient submits comments to HRSA regarding proposed revisions to the current 340B administrative dispute resolution final ruleVizient, Inc.
January 26 - Vizient comments to the Agency for Healthcare Research and Quality (AHRQ) on the request for information (RFI) on Creating a National Healthcare System Action Alliance To Advance Patient SafetyVizient, Inc.
January 12 - Vizient comments to the National Quality Forum (NQF) on the Measure Application Partnership’s (MAP) draft recommendations for CMSVizient, Inc.
January 9 - Vizient letter to CMS on 340B Remedy for Repayment of Unlawful Cuts to Part B 340B-Purchased DrugsVizient, Inc.
2022 Advocacy
December 6 - Vizient comments to CMS on request for information (RFI) on a National Directory of Healthcare Providers & Services (NDH)
Vizient, Inc.
November 29 - Vizient endorsed coalition letter in support of the Investing in Kids’ Mental Health Now ActVizient, Inc.
November 16 - Vizient endorsed coalition letter urging Congress to include the PASTEUR Act in year-end healthcare legislationVizient, Inc.
November 14 - Vizient urges Congress to prevent damaging hospital cuts from taking effectVizient, Inc.
November 11 - Vizient comments on the No Surprises Act request for information (RFI)Vizient, Inc.
November 8 - Vizient letter to the Office of the United States Trade Representative (USTR) urging continued tariff exclusions for critical medical productsVizient, Inc.
November 3 - Vizient comments to CMS on request for information (RFI), "Make Your Voice Heard: Promoting Efficiency and Equity within CMS Programs"Vizient, Inc.
November 2 - Vizient submits comments to Department of Commerce on Draft Harmonized System Code List of Critical Supply ChainsVizient, Inc.
October 6 - Vizient endorses the Biologics Competition Act of 2022Vizient, Inc.
September 30 - Vizient comments to HHS on the Office of Civil Rights' (OCR) Nondiscrimination in Health Programs and Activities Proposed RuleVizient, Inc.
September 14 – Vizient submits policy priority requests to congressional leadership for the remainder on the 117th CongressVizient, Inc.
September 12 - Vizient comments on the CY 2023 OPPS proposed ruleVizient, Inc.
September 7 - Vizient endorses the Improving Seniors’ Timely Access to Care Act of 2021Vizient, Inc.
September 6 - Vizient comments on the CY 2023 Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP) proposed ruleVizient, Inc.
August 30 - Vizient endorses the Assistance for Rural Community Hospitals (ARCH) ActVizient, Inc.
August 29 – Vizient comments to CMS on the proposed Conditions of Participation for Rural Emergency Hospitals and updates for Critical Access Hospitals.Vizient, Inc.
August 26 - Vizient comments to FDA on the revised draft guidance, "Identifying Trading Partners under the Drug Supply Chain Security Act (DSCSA)Vizient, Inc.
August 24 - Vizient comments on the Center for Medicare and Medicaid Services' (CMS) Medicare Program Request for Information (RFI)Vizient, Inc.
August 16 - Vizient urges FDA to identify strategies to increase the supply of certain medications and respond to drug shortagesVizient, Inc.
August 9 - Vizient comments on FDA's Draft Guidance on Risk Management Plans to Mitigate the Potential for Drug ShortagesVizient, Inc.
August 3 - Vizient endorses House version of the Travel Nursing Agency Transparency Study ActVizient, Inc.
July 19 – Vizient endorsed coalition letter urging HHS to issue guidance under the ACE Kids Act establishing a national definition to identify children with medically complex conditionsVizient, Inc.
July 11 - Vizient endorsed coalition letter urging continued support of the enhanced marketplace premium tax credits (PTCs) beyond 2022Vizient, Inc.
June 17 - Vizient comments on the FY 2023 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Prospective Payment System proposed ruleVizient, Inc.
June 14 - Vizient endorsed coalition letter in support of the Safety from Violence for Healthcare Employees (SAVE) ActVizient, Inc.
June 9 - Vizient endorses the Strengthen Kids’ Mental Health Now Act of 2022Vizient, Inc.
June 9 - Vizient endorses the Travel Nursing Agency Transparency Study ActVizient, Inc.
June 8 - Vizient endorses the Safety from Violence for Healthcare Employees (SAVE) ActVizient, Inc.
June 6 - Vizient submits recommendations to FDA to improve contrast media accessVizient, Inc.
June 3 - Vizient comments to FDA on the Quality Metrics (QM) Reporting ProgramVizient, Inc.
May 27 – Vizient endorsed coalition letter urging the House Energy and Commerce Committee to approve legislation to improve social determinants of healthVizient, Inc.
May 23 – Vizient joins HHS pledge to reduce carbon emissions in health careVizient, Inc.
May 12 - Vizient endorsed coalition letter in support of providing $718.8 million in funding for Children’s Hospital Graduate Medical EducationVizient, Inc.
May 13 - Vizient letter to United States Trade Representative and Director of the National Economic Council urging continued tariff exclusions for critical medical productsVizient, Inc.
May 4 - Vizient urges Congress to end the resumption of Medicare sequestration cuts and provide additional COVID-19 relief to healthcare providersVizient, Inc.
April 29 - Vizient submits comments to the Office of the National Coordinator for Health Information Technology Regarding the United States Core Data for Interoperability (USCDI) Draft Version 3Vizient, Inc.
April 20 - Vizient comments to House and Senate committee leadership on the discussion drafts of the Medical Device User Fee Amendments (MDUFA) of 2022 and the Prescription Drug User Fee Amendments (PDUFA) of 2022Vizient, Inc.
April 4 - Vizient comments to the Occupational Safety and Health Administration (OSHA) on the Emergency Temporary Standard, Occupational Exposure to COVID-19 in Healthcare SettingsVizient, Inc.
March 28 – Vizient joins several hospital organizations in urging HHS Secretary Becerra to extend the Public Health EmergencyVizient, Inc.
March 23 - Vizient comments on the White House Office of Science and Technology's (OSTP) Request for Information (RFI) on strengthening health through technologyVizient, Inc.
March 15 - Vizient joins health care other stakeholders in letter to Congress urging the inclusion of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act in upcoming user fee legislationVizient, Inc.
March 15 - Vizient endorses the Hospital Inpatient Services Modernization ActVizient, Inc.
March 10 - Vizient comments on the Republican Healthy Future Task Force Subcommittee on Treatment's Request for Information (RFI) on policy considerations and opportunities for improvement related to incentivizing and ensuring access to innovative treatmeVizient, Inc.
March 4 - Vizient comments to CMS on Health Equity Approaches related to Part C and D Star RatingsVizient, Inc.
February 28 - Vizient joins health care other stakeholders in letter to Congress urging an extension of the current Medicare sequester moratoriumVizient, Inc.
February 25 - Vizient comments to CMS on "Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals; Changes to Medicare Graduate Medical Education Payments for Teaching Hospitals; Changes to Organ Acquisition Payment PoliVizient, Inc.
February 18 - Vizient Statement on Passage of the Dr. Lorna Breen Health Care Provider Protection ActVizient, Inc.
February 10 - Vizient endorses the Provider Relief Fund Improvement ActVizient, Inc.
February 8 - Vizient urges Congress to provide more COVID-19 relief to healthcare providersVizient, Inc.
February 4 – Vizient joins other health care stakeholders in letter urging Senate leaders to include the LINC to Address Social Needs Act in the PREVENT Pandemics ActVizient, Inc.
February 4 - Vizient endorses the Opioid Treatment Access Act of 2022Vizient, Inc.
January 28 - Vizient comments to CMS on Request for Information (RFI) for Health and Safety Requirements for Transplant Programs, Organ Procrument Organzations (OPO), and End-Stage Renal Disease (ESRD) FacilitiesVizient, Inc.
January 26 - Vizient endorses the Drug Shortages Shelf Life Extension ActVizient, Inc.
January 24 - At Vizient’s Urging, Nearly 200 Members of Congress Write the White House Asking Them to Examine the Practices of Certain Nurse Staffing AgenciesVizient, Inc.
January 24 - Vizient submits additional policy requests to Congress on COVID-19 reliefVizient, Inc.
January 13 - Vizient comments to the National Quality Forum (NQF) on the Measure Application Partnership’s (MAP) draft recommendations for CMSVizient, Inc.
January 4 – Vizient comments on the Omnibus COVID-19 Health Care Staff Vaccination Interim Final RuleVizient, Inc.
2021 Advocacy
December 10 - Vizient Statement on Passage of the Protecting Medicare and American Farmers from Sequester Cuts Act
Vizient, Inc.
December 3 – Vizient comments on the Interim Final Rule on “Requirements Related to Surprise Billing: Part II"Vizient, Inc.
December 3 - Vizient comments to FDA on Hospital and Health System Compounding Under Section 503A of the Food, Drug and Cosmetic ActVizient, Inc.
December 2 - Vizient Statement on Release of the Continuing ResolutionVizient, Inc.
November 29 - Vizient joins health care other stakeholders in letter to Congress urging an extension of the moratorium on Medicare sequester and prevention of the statutory Pay-As-You-Go (PAYGO) sequester from taking effectVizient, Inc.
November 19 - Vizient endorses the Provider Relief Fund Improvement ActVizient, Inc.
November 1 - Vizient joins health care other stakeholders in letter to Congress urging the removal of reductions to the Medicaid disproportionate share hospital (DSH) program from the Build Back Better ActVizient, Inc.
November 1 - Vizient urges Congress to act on the sale of counterfeit medical suppliesVizient, Inc.
October 28 - Vizient joins other health care stakeholders in letter to governors on recent or impending expiration of licensure flexibilities for care across state linesVizient, Inc.
October 27 - Vizient comments to FDA on reauthorization of the Prescription Drug User Fee Act (PDUFA).Vizient, Inc.
October 20 - Vizient endorses the Social Determinants Accelerator ActVizient, Inc.
October 9 - Vizient provides additional information to DOT Port Envoy regarding health care supply chain port and shipping delaysVizient, Inc.
September 24 - Vizient comments to HRSA on COVID-19 Provider Relief Fund (PRF) reporting activitiesVizient, Inc.
September 23 – Vizient urges the U.S. Trade Representative to extend tariff relief for critical medical suppliesVizient, Inc.
September 21 - Vizient provides input to Congress on ways to address social determinants of healthVizient, Inc.
September 17 - Vizient comments on the CY 2022 Medicare Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems proposed ruleVizient, Inc.
September 13 - Vizient comments on the CY 2022 Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP) proposed ruleVizient, Inc.
September 9 - Vizient encourages congressional leadership to provide additional funding for health care providers in the upcoming budget reconciliation legislationVizient, Inc.
September 7 - Vizient comments on interim final rule on “Requirements Related to Surprise Billing; Part I”Vizient, Inc.
September 1 - Vizient supports increased investment in Medicare-supported GME positions in budget reconciliation legislationVizient, Inc.
August 13 - Vizient endorses the Preserving Patient Access to Home Infusion ActVizient, Inc.
July 30 - Vizient endorses the Provider Relief Fund Deadline Extension ActVizient, Inc.
June 29 - Vizient joins other health care stakeholders in opposing certain financing sources in future infrastructure legislationVizient, Inc.
June 28 – Vizient joins other health care stakeholders in letter to CMS on FY 2022 Inpatient Prospective Payment Systems Proposed Rule Graduate Medical Education ProposalsVizient, Inc.
June 28 - Vizient comments on the FY 2022 Inpatient Prospective Payment System proposed ruleVizient, Inc.
June 22 - Vizient joins other health care stakeholders in supporting the inclusion of the PASTEUR Act in disaster preparedness legislation.Vizient, Inc.
June 11 – Vizient joins other health care stakeholders in letter to CMS on Medicaid Supplemental Reporting Requirements in the Consolidated Appropriations Act of 2021Vizient, Inc.
May 19 – Vizient endorses the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health ActVizient, Inc.
May 19 - Vizient supports increased investment in Medicare-supported GME positions in future infrastructure packageVizient, Inc.
May 19 - Vizient endorses the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers ActVizient, Inc.
May 12 - Vizient requests that HHS provide additional clarity and flexibility for purposes of 340B program eligibilityVizient, Inc.
May 10 – Vizient joins other health care stakeholders in letter to HHS urging extension of the deadline by which providers must use their Provider Relief Fund (PRF) paymentsVizient, Inc.
May 3 - Vizient endorses the Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) ActVizient, Inc.
April 29 - Vizient endorses the Opioid Workforce Act of 2021Vizient, Inc.
April 16 – Vizient comments to HHS on Request for Information (RFI) on Termination of the FDA’s Unapproved Drugs InitiativeVizient, Inc.
April 9 - Vizient encourages support for providers in Congressional infrastructure legislationVizient, Inc.
March 31 - Vizient supports $485 million for Children's Hospital Graduate Medical Education (CHGME) for FY2022Vizient, Inc.
March 25: Vizient Requests Additional Information from CMS and CMMI Regarding the Medicare Shared Savings Program and Direct Contracting Model OptionsVizient, Inc.
March 25 – Vizient endorses the Strengthening Rural Health Clinics ActVizient, Inc.
March 24 – Vizient joins other health care stakeholders in support of the Resident Physician Shortage Reduction ActVizient, Inc.
March 24 – Vizient endorses the Resident Physician Shortage Reduction Act of 2021Vizient, Inc.
March 22 – Vizient joins other health care stakeholders in letter to FDA regarding the payer-mandated distribution models and the Drug Supply Chain Security Act (DSCSA)Vizient, Inc.
March 12 – Vizient urges Congressional leadership to extend the Medicare sequester moratorium and prevent the projected Medicare PAYGO spending cutVizient, Inc.
February 25 - Vizient encourages Senate leadership to provide additional funding for health care providers in the current budget reconciliation packageVizient, Inc.
February 12 - Vizient submits additional policy requests to Congress on COVID-19 reliefVizient, Inc.
February 3 – Vizient joins other health care stakeholders in urging a delay of the Medicare SequesterVizient, Inc.
February 2 – Vizient supports the Temporary Reciprocity to Ensure Access to Treatment (TREAT) ActVizient, Inc.
January 29 - Vizient Endorses Legislation to Extend the Moratorium on the Medicare SequesterVizient, Inc.
January 27 - Vizient applauds Congressional leaders for supporting physician workforceVizient, Inc.
January 25 - Vizient Urges CMS to Withdraw Harmful Most Favored Nation RuleVizient, Inc.
January 4 - Vizient comments to CMS on Reducing Provider and Patient Burden by Improving Prior Authorization Processes and Promoting Patients’ Electronic Access to Health InformationVizient, Inc.
2020 Advocacy
December 28 - Vizient comments to HHS on Request for Information (RFI) on Regulatory Relief to Support Economic Recovery
Vizient, Inc.
Dec. 22 - Vizient letter to the U.S. Trade Representative urging a continuation of Sec. 301 tariff exclusionsVizient, Inc.
Dec. 22 - Vizient comments to the Department of Commerce on policies to strengthen the U.S. public health industrial base.Vizient, Inc.
December 14 - Vizient endorsed coalition letter in support of the PASTEUR ActVizient, Inc.
December 10 – Vizient urges CMS to delay the start of Most Favored Nation (MFN) ModelVizient, Inc.
December 4 – Vizient comments to CMS on Public Health Focused Essential Medicines, MCM and Their Critical Inputs ListVizient, Inc.
November 18 - Vizient submits additional policy requests to Congress on COVID-19 reliefVizient, Inc.
November 12 - Vizient Urges Congress to Extend Sequestration MoratoriumVizient, Inc.
November 2 - Vizient comments to CMS on Third Interim Final Rule on Policy and Regulatory Revisions in Response to the COVID-19 Public Health EmergencyVizient, Inc.
October 14 - Vizient comments to NIOSH on CDC’s National Elastomeric Half Mask Respirator (EHMR) Strategy for Use in Healthcare SettingsVizient, Inc.
Oct. 13 - Vizient letter to HHS Regarding Changes to Provider Relief Fund GuidelinesVizient Office of Public Policy and Government Relations
October 5 - Vizient comments on the CY 2021 Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP) proposed ruleVizient, Inc.
October 5 - Vizient comments on the CY 2021 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed ruleVizient, Inc.
August 31 – Vizient comments to FDA on Approved Drug Products With Therapeutic Equivalence Evaluations (the “Orange Book”)Vizient, Inc.
August 24 - Vizient letter of support for the Safe Drugs ActVizient, Inc.
August 5 - Vizient signs coalition letter in support of finalizing Stark and Anti-Kickback Statute reformsVizient, Inc.
July 30 - Vizient endorsed coalition letter urging the exclusion of damaging surprise billing proposals in COVID-19 relief legislationVizient, Inc.
July 29 - Senate Finance Committee Testimony of Cathy DenningVizient Inc.
July 21 - Vizient submits policy requests to Congress on additional COVID-19 reliefVizient, Inc.
July 14 - Vizient urges Treasury and IRS to extend deadlines for tax-exempt hospitals to complete their Community Health Needs Assessment and implementation strategyVizient, Inc.
July 10 – Vizient endorsed coalition letter in support of enhanced Medicaid FMAP and rescinding the Medicaid Fiscal Accountability Regulation in supplemental coronavirus response legislationVizient, Inc.
July 10 - Vizient comments on the FY 2021 Inpatient Prospective Payment System proposed ruleVizient, Inc.
July 9 – Vizient endorsed coalition letter urging the inclusion of The Resident Physician Shortage Reduction Act in supplemental coronavirus response legislationVizient, Inc.
July 7 – Vizient submits policy requests to Congress on expansion of telehealth flexibilitiesVizient, Inc.
July 7 – Vizient comments to CMS on Policy and Regulatory Revisions in Response to the COVID-19 Public Health EmergencyVizient, Inc.
June 26 – Vizient comments to the USPTO regarding Patent Trial and Appeal Board Rules of Practice for Instituting on All Challenged Patent Claims and All Grounds and Eliminating the Presumption at Institution Favoring Petitioner as to Testimonial EvidenceVizient, Inc.
June 22 – Vizient submits comments to the Department of the Treasury and Federal Reserve Board on Main Street Lending Program Nonprofit LoansVizient, Inc.
May 11 – Vizient submits comments to DEA on Aggregate Production Quota Adjustments in Response to the Coronavirus Disease 2019 Public Health EmergencyVizient, Inc.
May 7 - Vizient joins hospital provider groups in urging support for liability protections for front-line providersVizient, Inc.
April 24 – Vizient submits comments to CMS on the Comprehensive Care for Joint Replacement ModelVizient, Inc.
April 23 - Vizient endorsed joint hospital letter to HHS/CMS re: Accelerated and Advanced PaymentsVizient, Inc.
April 16 - Vizient submits policy requests to Congress on COVID-19 reliefVizient, Inc.
March 23 – Vizient recommendations to the White House Coronavirus Task Force and FDA on Access to Chloroquine and HydroxychloroquineVizient, Inc.
March 16 – Vizient recommendations to the White House Coronavirus Task Force and CMS on Supply Strategies for Personal Protective Equipment and PharmaceuticalsVizient, Inc.
March 6 – Vizient comments on Importation of Prescription DrugsVizient, Inc.
March 6 – Vizient comments to CMS on the Hospital Survey for Specified Covered Outpatient DrugsVizient, Inc.
January 31 – Vizient Comments to CMS on Medicaid Fiscal Accountability RegulationVizient, Inc.
January 27 – Vizient Comments to FDA on Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin ProductsVizient, Inc.
Connect with Vizient to help you solve health care’s biggest challenges